Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma
Clinical trial NCT07615283 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07615283
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2030-05-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.